Ocular Therapeutix (NASDAQ: OCUL) revenue
Ocular Therapeutix reported revenue of $52.0m for fiscal 2025, 18.5% less than in fiscal 2024 ($63.7m). Since fiscal 2016 its revenue has grown by 2,653.1%, an average growth of 44.5% a year.
Ocular Therapeutix's best year of the last 10 was fiscal 2024. The biggest drop was in fiscal 2025, −18.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $52.0m | −18.5% | −$270.0m | −519.8% |
| 2024 | $63.7m | +9.0% | −$171.8m | −269.6% |
| 2023 | $58.4m | +13.5% | −$82.4m | −141.0% |
| 2022 | $51.5m | +18.3% | −$78.7m | −152.7% |
| 2021 | $43.5m | +150.1% | −$78.0m | −179.3% |
| 2020 | $17.4m | +311.7% | −$62.8m | −361.1% |
| 2019 | $4.2m | +112.4% | −$85.8m | −2,029.9% |
| 2018 | $2.0m | +3.5% | −$59.1m | −2,970.8% |
| 2017 | $1.9m | +1.9% | −$61.9m | −3,220.1% |
| 2016 | $1.9m | — | −$43.3m | −2,296.0% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Ocular Therapeutix revenue compared with its sector
By revenue for its latest fiscal year, Ocular Therapeutix ranks 327th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Ocular Therapeutix, −18.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 325th | Invivyd | $53.4m | 110.5% |
| 326th | Protalix Biotherapeutics | $52.7m | −1.2% |
| 327th | Ocular Therapeutix | $52.0m | −18.5% |
| 328th | Lexicon Pharmaceuticals | $49.8m | 60.2% |
| 329th | Protagonist Therapeutics | $46.0m | −89.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Ocular Therapeutix
- How much revenue did Ocular Therapeutix make in fiscal 2025?
- Ocular Therapeutix reported revenue of $52.0m for fiscal 2025, compared with $63.7m in fiscal 2024.
- How much has the revenue of Ocular Therapeutix grown?
- Between fiscal 2016 and fiscal 2025 it went from $1.9m to $52.0m: 2,653.1% more, an average growth of 44.5% a year.
- What was the best year for revenue at Ocular Therapeutix?
- Of its last 10 fiscal years, fiscal 2024, with $63.7m.
- Where does Ocular Therapeutix rank in its sector by revenue?
- It ranks 327th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Ocular Therapeutix come from?
- From the annual report (Form 10-K) that Ocular Therapeutix files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Ocular Therapeutix files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Ocular Therapeutix: the Ocular Therapeutix page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.